The risk of urinary tract infection (UTI) is higher in diabetics compared to non-diabetics. The aetiology and the antibiotic resistance of uropathogens have been changing over the past years. Hence the study was undertaken to determine if there are differences in clinical and microbiological features of UTI between diabetic and non-diabetic subjects, to study the influence of diabetes mellitus on the uropathogens and antibiotic sensitivity pattern in patients with UTI. Method A total of 181 diabetics (83 males and 98 females) and 124 non-diabetic subjects (52 males and 72 females) with culture positive UTI were studied. Patients with negative urine culture (n= 64), those diagnosed and treated outside (n= 83) and not willing to participate in the study (n= 24) were excluded. Results Almost 30 per cent of the patients (both diabetics and nondiabetics) presented with asymptomatic bacteriuria and the prevalence of pyelonephritis was significantly higher (p= 0.001. The isolation rate of Escherichia coli (E. coli) from urine culture was higher (64.6 per cent) among diabetic patients followed by Klebsiella (12.1 per cent) and Enterococcus (9.9 per cent). The prevalence of extendedspectrum beta-lactamase (ESBL) producing E.coli was significantly higher in diabetics (p= 0.001) compared to nondiabetics. E.coli showed maximum sensitivity to carbapenems in both diabetic and non-diabetic subjects and least susceptibility to ampicillin.
1. UTI is a significant problem both among diabetics and non-diabetics 2. E. coli is the most frequent pathogen responsible for UTI and recurrent UTI among both diabetics and non-diabetics followed by Klebsiella and Enterococcus. More than 75 per cent of the organisms including including ESBL E. coli, Pseudomonas and Acinetobacter were sensitive to amikacin and meropenem. 3. The widespread use of antimicrobial agents leads to emergence of drug resistant organisms. Since the pattern of bacterial resistance is constantly changing over years, it is important to monitor the antibiotic susceptibility patterns of isolated organisms to ensure rational use of antibiotics for empirical and definitive treatment of urinary tract infections in the vulnerable group. 0.04) in diabetics compared to non-diabetic patients. The majority of the diabetics with UTI (87.14 per cent) had glycosylated haemoglobin (HbA1c) > 6.5 per cent with p < Australasian Medical Journal [AMJ 2014, 7, 1, 29-34] 30 Background Diabetics are more prone to infections than their nondiabetic counterparts. The urinary tract is the most common site of infection in diabetic patients. Most of the urinary tract infections (UTIs) in diabetic patients are relatively asymptomatic, which can lead to severe kidney damage and renal failure. Bacteriuria is more common in diabetics than in non-diabetics due to a combination of host and local risk factors. 1 Disturbances (low complement factor 4, decreased cytokine response) in humoral innate immunity have been described in diabetic patients. 2 However, the clinical relevance of these findings is not clear. Concerning cellular innate immunity, most studies show decreased function in diabetic polymorphonuclear cells and monocytes/macrophages compared to controls. Improved control of the diabetes mellitus (DM) can lead to an improvement in these cellular functions. As well, some microorganisms become more virulent in a high glucose environment. 2 Therefore, screening for UTI in diabetic patients is very important to enable bacteruria to be properly treated, and prevent the development of renal complications of diabetes and eventually severe renal damage and failure. 3 However, controversies exist with respect to incidence, prevalence and microbiological features of UTI between diabetic and non-diabetic patients. 4 Hence the study was planned to compare clinical, microbiological and predisposing features of UTI in diabetics and non-diabetics. The aim of this study was to investigate if differences exist in the clinical and microbiological characteristics of UTI between diabetic and non-diabetic patients and to study the influence of diabetes mellitus on the spectrum of uropathogens and antimicrobial resistance pattern in patients with UTI.
Method
This was a prospective study conducted at the Department of Medicine at a tertiary care hospital in Karnataka. 
Results
The mean age among diabetic and non-diabetic patients was 60. Table 1 shows the clinical characteristics of the groups. There was no significant statistical difference in clinical symptoms between diabetic and non-diabetic subjects calculated by Chi-square test. Although fever was the most common presenting symptom, almost 30 per cent of the patients (both diabetics and non-diabetics) did not present with any urinary symptoms as shown in Figure 1 .
Figure 1: Asymptomatic bacteriuria
The prevalence of pyelonephritis is significantly higher (p= 0.04) in diabetics (9.4 per cent compared with non-diabetic patients 3.2 per cent ( Table 2 ). The most common organism isolated being E. coli (Table 3) . Benign prostatic hypertrophy (BPH) was the most common predisposing factor in both diabetic (38.5 per cent) and nondiabetic males (40.3 per cent) followed by catheterisation in diabetic (37.3 per cent) and non-diabetic (44.2 per cent) subjects (Table 4 ). The most common predisposing condition for UTI in females was the presence of indwelling catheter in diabetic (33.6 per cent) and non-diabetic (30.5 per cent) ( Table 4 ). There was no significant difference in the p-value (0.83) among both groups. The past history of UTI was observed in 27 per cent of diabetics and 18 per cent of non-diabetics. However this difference was also not statistically significant.
Among the complications, Acute Kidney Injury (AKI) was most common followed by recurrent UTI. Recurrent UTI was noted in 26 of 181 diabetics and 13 of 124 non-diabetic subjects. The prevalence of recurrent UTI was higher in diabetics (14.4 per cent) compared to non-diabetics (10.5 per cent); however difference was not statistically significant. The most common uropathogen among these patients was E. coli. More than 50 per cent of patients with recurrent UTI had HbA1c ≥ 8.0 (poorly controlled DM). Mean HbA1c in diabetics with recurrent UTI was 9.26 ± 3.83 (i.e. > 8.0). Renal papillary necrosis was observed in two cases of Candidial septicaemia. The micro-organisms isolated from the urine cultures are listed in Table 5 . The most common organism isolated among both diabetics and non-diabetics was E. coli. When patients with indwelling catheter were considered separately, the isolation rates of different uropathogens significantly differed only for pseudomonas in diabetic and non-diabetic groups (3.1 per cent vs 17.8 per cent) (p< 0.05). We observed a higher isolation rate of Pseudomonas spp. in non-diabetic males than that in diabetic males (15.4 per cent vs 3.6 per cent) (p < 0.05). Acinetobacter spp was isolated from urine cultures from three diabetic subjects, out of which twp patients also had positive blood cultures for the same organism and one case had endotracheal aspirate growth for Acinetobacter spp.
Candida spp. was isolated from both blood and urine cultures in five diabetic patients. The prevalence of ESBL E. coli was significantly higher in diabetics (p= 0.001) compared to non-diabetics.
The antimicrobial resistance pattern was similar in both groups with maximum sensitivity to meropenem and least susceptibility to ampicillin as noted in Table 6 . Aminoglycosides showed a better sensitivity profile than cefoperazone-sulbactum in both diabetics and nondiabetics; however the number of patients were too small to draw any conclusions from the above mentioned observation. Enterococcus showed maximum susceptibility to linidazole, teicoplanin and vancomycin. Of the five patients with coagulase positive staphylococcus, two cases were MRSA isolates which were sensitive to vancomycin and linidazole. 
Discussion
In the present study, there was no significant correlation between the age of patient and the incidence of UTI in both diabetic and non-diabetic patients. Bonadio M et al. (2006) also made a similar observation in his study (73.7 years in diabetics vs 72.7 years in non-diabetic subjects). 5 Bahl AL et al. (1970) found significant correlation between duration of diabetes and the prevalence of bacteriuria. 6 The prevalence of bacteriuria increased 1.9 fold for every 10 years of diabetes duration. This is probably due to higher prevalence of autonomic neuropathy and subsequent incomplete bladder emptying in longstanding diabetes. 7 However, such a correlation was not observed in our study. Zhanel GG et al. (1995) noted that the prevalence of UTI was significantly higher among patients on oral hypoglycaemic agents. 8 There was no correlation between type of treatment and the prevalence of UTI in the present study.
Fever was the most common symptom associated with UTI in both diabetics and non-diabetics. So, the presence of fever should prompt a look at the urinary tract as a possible source of infection. However; there was no significant difference in the clinical symptoms among both groups as shown in Table 1 . In the present study, no significant difference was found in the prevalence of asymptomatic bacteriuria (ASB) in females (diabetics 0. (2000) the prevalence of asymptomatic bacteriuria was higher in diabetic women when compared to non-diabetic women (26 per cent in diabetic subjects and 6 per cent in controls). 9 Bladder outlet obstruction due to BPH or urethral stricture was the predisposing factor in almost 40 per cent of males with UTI in this series. The presence of underlying autonomic neuropathy in these patients was not investigated. Most of the diabetic patients developing UTI in our study had long standing DM (> 5 years). Hence, probably these patients might require more intensive screening for the presence of bacteriuria and UTI.
The mean HbA1c level of the diabetic patients at the time of admission was 8.42 per cent ± 2.8 SD in our study compared with Bonadio M et al. (2006) (the mean HbA1c level being 7.8 per cent ± 1.6 SD). 5 Majority of the diabetics with UTI (87.14 per cent ) had HbA1c > 6.5 per cent with p < A high proportion of patients (88.8 per cent) with HbA1c < 6.5 and UTI had other underlying factors such as bladder outlet obstruction or indwelling catheter which predisposed them to UTI. Thus the occurrence of UTI in diabetics seems to be related to the glycaemic control in the recent (weeks to months). Schmitt JK et al. (1986) analysed the correlation between asymptomatic bacteriuria and HbA1c and found no statistically significant association between the degree of glycemic control and UTI. A higher incidence of elevated blood glucose levels was observed in 13 In the present study, we observed that the spectrum of uropathogens and antimicrobial resistance patterns among patients with catheter associated UTI were different from those observed in other hospitals. This may depend on the different policy of antibiotics used in the various hospitals and the inclusion of higher number of nosocomial UTIs in our study.
Fungal UTI among diabetic population are more common in patients with prolonged hospital stay, catheterisation and prolonged parenteral antibiotic use. 14 In the present study five patients had UTI due to Candida. These patients had other factors predisposing to UTI and/or prolonged hospital stay.
Regarding the antimicrobial resistance profile of the uropathogens, we observed that the isolated E. coli strains were resistant at similar rates to ampicillin, cotrimoxazole, norfloxacin and cephalosporins ( 
Conclusion
The prevalence of pyelonephritis is significantly higher in diabetics than in non-diabetic subjects. Elevated HbA1c correlates with occurrence of UTI and the predisposition of the diabetic to UTI depends on the degree of glycaemic control over a period of weeks to months. Achieving an HbA1c < 6.5 per cent appears to protect those diabetics who do not have other underlying predisposing factors for UTI. An HbA1c > 8.0 per cent in patients with diabetes mellitus increases the chance of developing UTI and its recurrence. E. coli is the most frequent pathogen responsible for UTI and recurrent UTI among both diabetics and non-diabetics followed by Klebsiella and Enterococcus. Investigation of bacteriuria in diabetic patients for urinary tract infection is important for treatment and prevention of the development of renal complications.
